Swedencare AB · OMXSTO:SECARE
Swedencare AB — Merger or Acquisition (September 2020)
9 slides from Swedencare AB's merger presentation, September 2020
Slide 1: Swedencare
Swedencare Sept 2020
Slide 2: Creating a "new" Swedencare
Swedencare’s acquisitions of Nutravet & animal pharmaceuticals Creating a ”new” Swedencare
Slide 3: Swedencare's Nutravet acquisition in short
Swedencare’s nutravet acquisition in short • Vet exclusive with thousands of vet practices in customer base • European expansion through long-term agreement with leading European vet-chain • Innovative and extensive product portfolio in multiple therapeutic areas • Market leading profitability • Acq
Slide 4: Nutravet acquisition - financials
Swedencare’s nutravet acquisition - financials TTM GBP (000) July 2019 - June 2020 Net revenue 5 362 Gross profit 3 831 Gross profit (%) 71,4% EBITDA 2 759 EBITDA (%) 51,5% SEK (000) Net revenue 60 855 Gross profit 43 478 EBITDA 31 310 EBITDA (%) 51,5% Extraordinary EBITDA due to high gross margin &
Slide 5: Animal Pharmaceuticals (AP) acquisition in short
Swedencare’s animal pharmaceuticals (“AP”) acquisition in short • Strong presence in vet-channel with a >8 500 vet practices customer base • Of which <10% are customers to Stratford • Extensive product portfolio in multiple therapeutic areas • Perfect complement to Stratford, creating an independent
Slide 6: AP acquisition - financials
Swedencare’s ap acquisition - financials TTM USD (000) July 2019 - June 2020 Net revenue 6 357 Gross profit 3 284 Gross margin (%) 51,7% EBITDA 2 183 EBITDA (%) 34,3% SEK (000) Net revenue 55 624 EBITDA 19 101 EBITDA (%) 34,3% High profit margin due to healthy gross margins and low OPEX
Slide 7: Three acquisitions in three months, a new Swedencare emerges
three acquisitions in three months Animal Swedencare Stratford Nutravet Pharmaceuticals Acquisitions Consolidated TTM July 2019 - June 2020 Figures in ´000 SEK Total sales 135 814 79 242 60 855 55 624 195 721 331 535 Gross profit 98 635 38 397 43 478 28 734 110 609 209 243 Gross profit (%) 72,6% 48,
Slide 8: ... as the leading OTC pet health care company
… as the leading otc pet health care company SWEDENCARE PRE VS POST THE THREE ACQUISITIONS (TTM JULY 2019 - JUNE 2020) TSEK 350 000 300 000 Sales +144% 250 000 EBITDA +177% 200 000 150 000 100 000 50 000 0 Sales 135 814 195 721 331 535 EBITDA 37 411 66 353 103 764
Slide 9: Our targets and vision
Our targets and vision “Our vision is to Establish Ourselves as the Leading Company within dental and oral Health for the pet market.” “Swedencare shall pay a dividend that takes into account the Group's earnings trend- and consolidation and investment needs, liquidity and financial position. The go